Amyloidosis Therapeutics Market contains market size and forecasts of Amyloidosis Therapeutics in global, including the following market information:
- Global Amyloidosis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Amyloidosis Therapeutics Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Amyloidosis Therapeutics companies in 2021 (%)
The global Amyloidosis Therapeutics market was valued at 4720.2 million in 2021 and is projected to reach US$ 6652.5 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
AG-10 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amyloidosis Therapeutics include Pfizer Inc., ProteoTech, Inc., Alnylam Pharmaceuticals, Inc., Arcturus Therapeutics, Inc, Bellus Health Inc., Bsim2, Celgene Corporation, Millennium Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amyloidosis Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amyloidosis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Amyloidosis Therapeutics Market Segment Percentages, by Type, 2021 (%)
- AG-10
- ALN-ANG
- ALN-TTRsc02
- CAEL-101
- Canakinumab
- Others
Global Amyloidosis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Amyloidosis Therapeutics Market Segment Percentages, by Application, 2021 (%)
- AL Amyloidosis
- AA Amyloidoses
- ATTR Amyloidoses
- Others
Global Amyloidosis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Amyloidosis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Amyloidosis Therapeutics revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Amyloidosis Therapeutics revenues share in global market, 2021 (%)
- Key companies Amyloidosis Therapeutics sales in global market, 2017-2022 (Estimated), (K Pcs)
- Key companies Amyloidosis Therapeutics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer Inc.
- ProteoTech, Inc.
- Alnylam Pharmaceuticals, Inc.
- Arcturus Therapeutics, Inc
- Bellus Health Inc.
- Bsim2
- Celgene Corporation
- Millennium Pharmaceuticals, Inc.
- Onyx Pharmaceuticals, Inc.
- GlaxoSmithKline Plc
- Isis Pharmaceuticals, Inc.
- Prothena Corporation Plc
- SOM Innovation Biotech SL
Industry Market Size
